# Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prophylaxis Against Atrial Fibrillation After on Pump Coronary Artery Bypass Surgery

Study · id `cardio:ct-nct03800264` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03800264](<https://clinicaltrials.gov/study/NCT03800264>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03800264

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.

## Technical summary

Registry record NCT03800264. Randomized; single masking; primary purpose prevention. Start 2018-05-02 (actual); primary completion 2018-11-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 176 participants (enrolled count; ClinicalTrials.gov record NCT03800264, source copy `cardio:ctgov-nct03800264-2019-01-15`, retrieved 2026-10-26)
- Started: 2018-05-02 (actual) (ClinicalTrials.gov record NCT03800264, source copy `cardio:ctgov-nct03800264-2019-01-15`, retrieved 2026-10-26)
- Primary completion: 2018-11-01 (actual) (ClinicalTrials.gov record NCT03800264, source copy `cardio:ctgov-nct03800264-2019-01-15`, retrieved 2026-10-26)
- Completion: 2018-11-15 (actual) (ClinicalTrials.gov record NCT03800264, source copy `cardio:ctgov-nct03800264-2019-01-15`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT03800264, source copy `cardio:ctgov-nct03800264-2019-01-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03800264-2019-01-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prophylaxis Against Atrial Fibrillation After on Pump Coronary Artery Bypass Surgery
- Condition: Prevention
- Condition: Atrial Fibrillation
- Condition: CABG
- Intervention (Drug): Bisoprolol
- Lead sponsor: Ain Shams University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Bisoprolol (`cardio:bisoprolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Ain Shams University (`cardio:org-ain-shams-university`)

## Provenance

Content hash: 76945ccc976b425f294c3336cced7da28088df6f05ed229432813598f10c54bb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
